Reports from Nippon Medical School Add New Data to Findings in Non-Small Cell Lung Cancer (Paper Serum-derived Exosomal Mir-125a-3p Predicts the Response To Anti-programmed Cell Death-1/programmed Cell Death-ligand 1 Monotherapy In Patients...).

Keywords: Tokyo; Japan; Asia; Cancer; Drugs and Therapies; Genetics; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology EN Tokyo Japan Asia Cancer Drugs and Therapies Genetics Health and Medicine Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology 960 960 1 06/19/23 20230620 NES 230620 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Data detailed on Oncology - Non-Small Cell Lung Cancer have been presented. For more information on this research see: Paper Serum-derived Exosomal Mir-125a-3p Predicts the Response To Anti-programmed Cell Death-1/programmed Cell Death-ligand 1 Monotherapy In Patients With Non-small Cell Lung Cancer. [Extracted from the article]